VPS33A and Cholestatic liver disease: Interestingly, pathogenic variants in several components of the endosomal system (e.g., in VP16 and VPS33A) cause cholestatic liver disease in humans that is accurately modeled by loss-of-function mutations in the zebrafish (42, 43).